Ads

What is benign prostatic hyperplasia icd 10 ?(Jan 2024)

 

What is benign prostatic hyperplasia icd 10 ?(Jan 2024)

What is benign prostatic hyperplasia icd 10 ?


This condition is a histologic diagnosis that may lead to lower urinary tract symptoms



Benign Prostatic Hyperplasia (BPH) is a common condition in aging men, characterized by the proliferation of glandular epithelial tissue, smooth muscle, and connective tissue within the prostate gland. It is identified by the International Classification of Diseases (ICD) code 600. The ICD-10 code for benign prostatic hyperplasia is N40. This condition is a histologic diagnosis that may lead to lower urinary tract symptoms. The age-standardized prevalence of BPH is high, particularly in aging men. BPH can cause lower urinary tract symptoms and may lead to complications such as bladder outlet obstruction. Management of BPH includes various medical and minimally invasive treatment options.


Symptoms 


The symptoms of benign prostatic hyperplasia (BPH) can include:
  • Frequent or urgent need to urinate
  • Increased frequency of urination at night
  • Difficulty starting urination
  • Weak urine stream
  • Intermittent urine flow
  • Dribbling at the end of urination
  • Inability to completely empty the bladder
  • Less common symptoms may include urinary tract infections, inability to urinate, and blood in the urine


 Cause of (BPH)


The exact cause of benign prostatic hyperplasia (BPH) is not well understood, but several factors are believed to contribute to its development. Some of the factors that may play a role in the development of BPH include:
  1. Aging: BPH is more common in older men and rare in men whose testicles were removed before puberty.
  2. Testosterone: Throughout their lives, men produce testosterone, a male hormone. Some researchers believe that factors related to aging and the testicles may cause BPH.
  3. Dihydrotestosterone (DHT): Older men continue to produce and accumulate high levels of DHT in the prostate. This accumulation of DHT may encourage prostate cells to continue to grow.
  4. Cellular changes: Scientists have noted that men who do not produce DHT do not develop BPH.

(BPH) can affect urination in several ways


Benign prostatic hyperplasia (BPH) can affect urination in several ways. When the prostate is enlarged, it can obstruct the flow of urine out of the bladder, leading to various symptoms. Some of the common effects on urination include:
  • Frequent or urgent need to urinate
  • Increased frequency of urination at night
  • Difficulty starting urination
  • Weak urine stream
  • Intermittent urine flow
  • Dribbling at the end of urination
  • Inability to completely empty the bladder
  • Less common symptoms may include urinary tract infections, inability to urinate, and blood in the urine


Diagnosis


The diagnosis of benign prostatic hyperplasia (BPH) typically involves a combination of medical history, physical examination, and diagnostic tests. The healthcare provider will start by asking questions about the individual's symptoms and medical history. A physical exam, including a digital rectal exam (DRE), may be performed to assess the size, shape, and consistency of the prostate gland. Diagnostic tests may include:
  • Prostate-specific antigen (PSA) blood test: PSA is a protein made in the prostate, and its levels go up when the prostate becomes enlarged. However, higher PSA levels can also be due to recent procedures, illnesses, surgery, or prostate cancer.

  • Urinary flow test: This test involves peeing into a container attached to a machine that measures the flow rate and volume of urine.
  • Transrectal ultrasound and prostate biopsy: These tests may be used to confirm the diagnosis if there is suspicion for prostate cancer.
  • Cystoscopy, ultrasound, or prostate MRI: These tests may also be used to confirm the diagnosis.

Treatment for benign prostatic hyperplasia


The treatment for benign prostatic hyperplasia (BPH) depends on the severity of the symptoms and the individual's preferences. The main treatment options include lifestyle changes, medications, and surgical procedures.
  1. Lifestyle changes: Some simple changes to your lifestyle may help relieve the symptoms of BPH. These include drinking fewer fizzy drinks, less alcohol, caffeine, and artificial sweeteners.
  2. Medications: If lifestyle changes do not help or are not suitable for you, you may be offered medication. There are several types of medications used to treat BPH, such as:Alpha blockers: These relax the muscle in your prostate gland and at the base of your bladder, making it easier to urinate.
  3. Surgery and other procedures: If medications do not provide enough relief or if the symptoms are severe, surgery or other procedures may be considered. Some common surgical options include:Transurethral resection of the prostate (TURP): This procedure uses electric current or laser light to cut and remove tissue from the prostate

Medications

  • Alpha blockers: These relax the muscle in your prostate gland and at the base of your bladder, making it easier to urinate.
  • Anticholinergics: These relax the bladder muscle if it's overactive.
  • 5-alpha reductase inhibitors: These are used to treat larger prostate glands and shrink the prostate gland if it's enlarged

    .
  • Diuretics: These speed up urine production and reduce the amount of urine produced at night.
  • Desmopressins: These slow down urine production so less urine is produced at night.
  • Mirabegron: This medicine relaxes the bladder muscle and improves urine flow

Servival rate

The survival rate for adenomatous hyperplasia (AH) varies based on the treatment method. According to the study, the overall survival rates at 5 years were 89.6% for patients treated by surgery and 71.9% for those treated by ethanol injection. This indicates a higher survival rate for patients who underwent surgery compared to those treated with ethanol injection.The study's findings suggest that surgical resection resulted in a better overall survival rate at 5 years for patients with AH. It is important to note that individual cases may vary, and treatment decisions should be made based on a thorough evaluation of each patient's condition and in consultation with healthcare providers.

Risk factors

Endometrial hyperplasia, characterized by abnormal thickening of the uterine lining, is associated with various identifiable risk factors. These factors play a role in the development and progression of endometrial hyperplasia:
  1. Estrogen Exposure:
    • Chronic exposure to estrogen without sufficient progesterone balance can lead to endometrial hyperplasia. Factors like irregular menstrual periods, obesity, and polycystic ovary syndrome (PCOS) can disrupt ovulation and reduce progesterone exposure.
  2. Age and Menstrual History:
    • Women over 35 years old, especially those who started menstruating early, never became pregnant, experienced infertility, or had late menopause, are at higher risk of developing endometrial hyperplasia.
  3. Medical Conditions:
    • Conditions like diabetes, thyroid disease, gallbladder disease, Lynch syndrome, Cowden syndrome, and tumors that secrete estrogen can increase the risk of endometrial hyperplasia.
  4. Medications:
    • Certain medications like tamoxifen (used for breast cancer) and prescription estrogen without progesterone can contribute to the development of endometrial hyperplasia.
  5. Obesity:
    • Obesity is a significant risk factor for endometrial hyperplasia as fat tissue can convert other hormones into estrogen, impacting hormone levels and potentially leading to abnormal uterine lining growth.
  6. Genetic Factors:
    • Genetic disorders like Lynch syndrome and Cowden syndrome are associated with an increased risk of endometrial hyperplasia due to their impact on cell growth regulation.

Conclusion 


Benign prostatic hyperplasia (BPH) is a common condition in aging men, characterized by the proliferation of glandular epithelial tissue, smooth muscle, and connective tissue within the prostate gland. The ICD-10 code for BPH is N40. The condition can lead to various urinary symptoms, such as frequent urination, weak urine stream, and difficulty emptying the bladder. The diagnosis typically involves a medical history, physical examination, and may include tests such as a PSA blood test, urinary flow test, and imaging studies. 

Treatment options range from lifestyle changes and medications to surgical procedures, depending on the severity of symptoms. It's important for individuals experiencing symptoms of BPH to seek medical advice for an accurate diagnosis and appropriate management.

Post a Comment

0 Comments
* Please Don't Spam Here. All the Comments are Reviewed by Admin.